Abstract: The present disclosure provides compounds which are peptides comprising the amino acid sequence of the formula (I) disclosed herein or pharmaceutically acceptable salts thereof. The compounds act as agonists of the corticotropin-releasing factor receptor 2 (CRF2) and are useful in therapy, especially in the treatment or prevention of cardiovascular diseases, obesity and diabetes.
| # | Name | Date |
|---|---|---|
| 1 | 202317017533.pdf | 2023-03-15 |
| 2 | 202317017533-STATEMENT OF UNDERTAKING (FORM 3) [15-03-2023(online)].pdf | 2023-03-15 |
| 3 | 202317017533-Sequence Listing in txt [15-03-2023(online)].txt | 2023-03-15 |
| 4 | 202317017533-Sequence Listing in PDF [15-03-2023(online)].pdf | 2023-03-15 |
| 5 | 202317017533-PRIORITY DOCUMENTS [15-03-2023(online)].pdf | 2023-03-15 |
| 6 | 202317017533-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [15-03-2023(online)].pdf | 2023-03-15 |
| 7 | 202317017533-FORM 1 [15-03-2023(online)].pdf | 2023-03-15 |
| 8 | 202317017533-DRAWINGS [15-03-2023(online)].pdf | 2023-03-15 |
| 9 | 202317017533-DECLARATION OF INVENTORSHIP (FORM 5) [15-03-2023(online)].pdf | 2023-03-15 |
| 10 | 202317017533-COMPLETE SPECIFICATION [15-03-2023(online)].pdf | 2023-03-15 |
| 11 | 202317017533-FORM-26 [15-06-2023(online)].pdf | 2023-06-15 |
| 12 | 202317017533-FORM 3 [19-06-2023(online)].pdf | 2023-06-19 |
| 13 | 202317017533-Proof of Right [17-10-2023(online)].pdf | 2023-10-17 |
| 14 | 202317017533-FORM 3 [27-03-2024(online)].pdf | 2024-03-27 |
| 15 | 202317017533-FORM 18 [21-05-2024(online)].pdf | 2024-05-21 |